139 related articles for article (PubMed ID: 7499197)
1. Ionizable P1 residues in serine proteinase inhibitors undergo large pK shifts on complex formation.
Abul Qasim M; Ranjbar MR; Wynn R; Anderson S; Laskowski M
J Biol Chem; 1995 Nov; 270(46):27419-22. PubMed ID: 7499197
[TBL] [Abstract][Full Text] [Related]
2. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
[TBL] [Abstract][Full Text] [Related]
3. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB.
Bateman KS; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
Protein Sci; 2000 Jan; 9(1):83-94. PubMed ID: 10739250
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
Lee TW; Qasim MA; Laskowski M; James MN
J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
[TBL] [Abstract][Full Text] [Related]
6. Binding of amino acid side-chains to S1 cavities of serine proteinases.
Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
[TBL] [Abstract][Full Text] [Related]
7. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
8. Replacement of P1 Leu18 by Glu18 in the reactive site of turkey ovomucoid third domain converts it into a strong inhibitor of Glu-specific Streptomyces griseus proteinase (GluSGP).
Komiyama T; Bigler TL; Yoshida N; Noda K; Laskowski M
J Biol Chem; 1991 Jun; 266(17):10727-30. PubMed ID: 1674942
[TBL] [Abstract][Full Text] [Related]
9. Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB).
Qasim MA; Wang L; Qasim S; Lu S; Lu W; Wynn R; Yi ZP; Laskowski M
FEBS Lett; 2013 Sep; 587(18):3021-6. PubMed ID: 23892073
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
11. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
Bigler TL; Lu W; Park SJ; Tashiro M; Wieczorek M; Wynn R; Laskowski M
Protein Sci; 1993 May; 2(5):786-99. PubMed ID: 8495199
[TBL] [Abstract][Full Text] [Related]
12. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
Lu W; Qasim MA; Laskowski M; Kent SB
Biochemistry; 1997 Jan; 36(4):673-9. PubMed ID: 9020764
[TBL] [Abstract][Full Text] [Related]
13. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
[TBL] [Abstract][Full Text] [Related]
14. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
[TBL] [Abstract][Full Text] [Related]
15. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics and kinetics of the hydrolysis and resynthesis of the reactive site peptide bond in turkey ovomucoid third domain by aspergillopeptidase B.
Ardelt W; Laskowski M
Acta Biochim Pol; 1983; 30(2):115-26. PubMed ID: 6346765
[TBL] [Abstract][Full Text] [Related]
17. Structure of the complex of Streptomyces griseus proteinase B and polypeptide chymotrypsin inhibitor-1 from Russet Burbank potato tubers at 2.1 A resolution.
Greenblatt HM; Ryan CA; James MN
J Mol Biol; 1989 Jan; 205(1):201-28. PubMed ID: 2494344
[TBL] [Abstract][Full Text] [Related]
18. Protein inhibitors of serine proteinases: role of backbone structure and dynamics in controlling the hydrolysis constant.
Song J; Markley JL
Biochemistry; 2003 May; 42(18):5186-94. PubMed ID: 12731859
[TBL] [Abstract][Full Text] [Related]
19. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
Song J; Markley JL
J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
[TBL] [Abstract][Full Text] [Related]
20. 1.2A-resolution crystal structures reveal the second tetrahedral intermediates of streptogrisin B (SGPB).
Lee TW; James MN
Biochim Biophys Acta; 2008 Feb; 1784(2):319-34. PubMed ID: 18157955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
